| |
 |
|
Class Information
Number: 424/277.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Cancer cell or component thereof
Description: Subject matter involving a cancer cell or a component of a cancer cell.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7105161 |
Proteinaceous adjuvants |
Sep. 12, 2006 |
| 7105162 |
Pharmaceutical composition for immunomodulation based on peptides and adjuvants |
Sep. 12, 2006 |
| 7105155 |
Method and activated lymphocyte preparations for preventing recurrence of carcinoma |
Sep. 12, 2006 |
| 7098306 |
Method and compositions for treating hepatocellular cancer |
Aug. 29, 2006 |
| 7097846 |
35 kD tumor associated protein antigen: uses and methods of detection |
Aug. 29, 2006 |
| 7098311 |
Fusion of jAZF1 and jjAZ1 genes in endometrial stromal tumors |
Aug. 29, 2006 |
| 7063854 |
Composition and methods for WTI specific immunotherapy |
Jun. 20, 2006 |
| 7060284 |
Polypeptides and polynucleotides for enhancing immune reactivity to HER-2 protein |
Jun. 13, 2006 |
| 7060279 |
Compositions and methods for dendritic cell-based immunotherapy |
Jun. 13, 2006 |
| 7056689 |
Methods of treating and detecting cancer using viruses |
Jun. 6, 2006 |
| 7052703 |
T-cell receptor.gamma. alternate reading frame protein, (TARP) and uses thereof |
May. 30, 2006 |
| 7041302 |
Therapeutic modulation of the tumor inflammatory response |
May. 9, 2006 |
| 7029678 |
Vaccines |
Apr. 18, 2006 |
| 7022819 |
Isolated nucleic acid molecule coding for tumor rejection antigen precursors MAGE-C1 and MAGE-C2 and uses thereof |
Apr. 4, 2006 |
| 7022496 |
Use of gene product of adenovirus early region 4 ORF-6 to inhibit repair of double-strand breaks in DNA |
Apr. 4, 2006 |
| 7018637 |
Multi-oligosaccharide glycoconjugate bacterial meningitis vaccines |
Mar. 28, 2006 |
| 7018632 |
Method for ex vivo immunization using heterologous intact bispecific and/or trispecific antibodies |
Mar. 28, 2006 |
| 7014856 |
Ganglioside-KLH conjugate vaccines plus OS-21 |
Mar. 21, 2006 |
| 7005126 |
Method for tumor treatment using infusion of xenogeneic cells to induce hyperacute rejection and innocent bystander effect |
Feb. 28, 2006 |
| 7001601 |
Ganglioside-KLH conjugate vaccine plus QS-21 |
Feb. 21, 2006 |
| 6994853 |
Time-staggered utilization of tumor cells in combination with intact antibodies for immunization |
Feb. 7, 2006 |
| 6987091 |
Sir2 products and activities |
Jan. 17, 2006 |
| 6984389 |
Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality |
Jan. 10, 2006 |
| 6972128 |
Use of human prostrate cell lines in prostate cancer treatment |
Dec. 6, 2005 |
| 6967022 |
Ganglioside-KLH conjugate vaccines plus QS-21 |
Nov. 22, 2005 |
| 6951917 |
MHC-class II restricted melanoma antigens and their use in therapeutic methods |
Oct. 4, 2005 |
| 6946133 |
Prostate specific antigen oligo-epitope peptide |
Sep. 20, 2005 |
| 6942862 |
Methods and compositions to generate immunity in humans against self tumor antigens by immunization with homologous foreign proteins |
Sep. 13, 2005 |
| 6936253 |
Ganglioside-KLH conjugate vaccines plus QS-21 |
Aug. 30, 2005 |
| 6930097 |
Matrix metalloproteinase and tumor necrosis factor inhibitors |
Aug. 16, 2005 |
| 6916476 |
Ganglioslide-KLH conjugate vaccine plus QS-21 |
Jul. 12, 2005 |
| 6899863 |
Method for preparing membrane vesicles |
May. 31, 2005 |
| 6897288 |
Mage-A12 antigenic peptides and uses thereof |
May. 24, 2005 |
| 6893643 |
Recombinant yellow fever virus and methods of use thereof |
May. 17, 2005 |
| 6875451 |
Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
Apr. 5, 2005 |
| 6858204 |
Compositions and methods for the therapy and diagnosis of lung cancer |
Feb. 22, 2005 |
| 6844188 |
Methods and modified cells for the treatment of cancer |
Jan. 18, 2005 |
| 6844000 |
Use of Parapox B2L protein to treat cancer and modify immune responses |
Jan. 18, 2005 |
| 6838086 |
Composition comprising low molecular weight hyaluronic acid fragments |
Jan. 4, 2005 |
| 6821522 |
Tumor Therapy |
Nov. 23, 2004 |
| 6821518 |
Compounds and methods for therapy and diagnosis of lung cancer |
Nov. 23, 2004 |
| 6821517 |
Compositions and methods for enhancing immune responses mediated by antigen-presenting cells |
Nov. 23, 2004 |
| 6814981 |
Ganglioside immunostimulating complexes and uses thereof |
Nov. 9, 2004 |
| 6809179 |
Tumor-associated antigen (R11) |
Oct. 26, 2004 |
| 6805869 |
Cellular vaccines and immunotherapeutics and methods for their preparation |
Oct. 19, 2004 |
| 6773707 |
Heat shock protein-based vaccines and immunotherapies |
Aug. 10, 2004 |
| 6761892 |
Heat shock protein-based vaccines and immunotherapies |
Jul. 13, 2004 |
| 6756477 |
Compositions and methods for the therapy and diagnosis of breast cancer |
Jun. 29, 2004 |
| 6756038 |
Agonist and antagonist peptides of carcinoembryonic antigen (CEA) |
Jun. 29, 2004 |
| 6749846 |
Interferon-beta use in the treatment of ewing's family of tumors |
Jun. 15, 2004 |
|
|
|
